RY has broad sell-side coverage, but its targets are complicated by the fact that the bank is primarily analyzed in Canadian dollars on the Toronto Stock Exchange while also trading on the NYSE. Converted to U.S. dollars, individual 12-month targets reported across sources range from about $186 to $235, and the arithmetic mean of the widest set of targets converts to only about $212 — roughly 5% to 6% above the current price. Because that level sits too close to the market price to be meaningful, this article uses the higher, publicly discussed $225 objective (MarketBeat's reported average of $225 across 13 analysts, and eToro's roughly $224) as its central reference point rather than presenting it as a single clean consensus.
For context, recent named Canadian-dollar targets illustrate the disagreement: National Bank Financial lifted its target to C$321 (Outperform) and Desjardins set C$320 (Buy), while Canaccord Genuity raised its target to C$318 (Buy). More cautious desks include CIBC at C$300 (Neutral) and Jefferies at C$271 after its earlier downgrade to Hold. The range of views — from outright Buy/Outperform ratings to Neutral and Hold — reflects debate over whether RBC's premium multiple is fully justified by its earnings power. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At a recent close near $201.16, RY sits close to the upper end of its 52-week range of roughly $143 to $219. Reaching $225 would require a move of about 12%, a substantial but not extreme advance for a large-cap bank over a typical analyst horizon. Royal Bank of Canada trades at roughly 17 times trailing earnings with a dividend yield near 2.4%, reflecting a market capitalization of about $280 billion.
A path toward $225 would most likely depend on continued execution across its capital-markets and wealth franchises, stable-to-rising net interest income, and modest valuation support — rather than any single catalyst. The stock has already re-rated meaningfully from its 52-week low, which means further gains hinge more on sustained earnings delivery than on a reset of its multiple.
RY's longer-term structure is constructive: the stock has climbed from its 52-week low near $143 toward recent highs just below $219. The round $200 level now acts as a key psychological area, with the prior high near $218–$219 representing the nearest clear resistance level ahead of the $225 objective. A sustained move above that prior high would be the most significant structural step toward the target, while a retreat below roughly $200 would signal fading momentum and put the recent uptrend in question.
Most analyst price targets carry a roughly 12-month research horizon, though individual firms apply different frameworks and some Canadian-dollar targets are not directly comparable to U.S.-dollar quotes. Investors tracking the $225 objective should watch quarterly earnings and guidance, net interest margin trends, credit-loss provisions, dividend announcements, and any further analyst target revisions. Macroeconomic data on Canadian housing, consumer health, and central-bank rate decisions, along with CAD/USD moves, will also shape the path toward the target.
Whether RY can reach $225 depends on sustaining above-peer profitability while avoiding a meaningful slowdown in trading income or credit quality. The roughly 12% required move is achievable but not trivial, and analyst views are genuinely split — with bullish targets clustered in the low-to-mid $220s and more cautious desks near $190 to $210. Strong fiscal 2025 results, a dividend increase, and favorable revisions support the case; a premium valuation, potential trading normalization, and Canadian credit risk are the main obstacles. Investors should focus on earnings delivery, margin trends, and whether the shares can clear the prior high near $219.
In my own research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor momentum on names like RY alongside the fundamental picture. The tool applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market shifts. It serves as a practical complement when tracking a target like $225 or watching for any early signs of trend changes in the financial sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for RY turned positive on October 15, 2026. Looking at past instances where RY's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on RY as a result. In 32 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 43%.
RY moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RY crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 23%.
Following a +1.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where RY advanced for three days, in 167 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
The Aroon Indicator entered an Uptrend today. In 148 of 326 cases where RY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 45%.
The 10-day RSI Indicator for RY moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 16 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 37%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 24 of 54 cases where RY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
RY broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. RY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.080) is normal, around the industry mean (1.500). P/E Ratio (12.652) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (2.257) is also within normal values, averaging (2.139). Dividend Yield (0.025) settles around the average of (0.035) among similar stocks. RY's P/S Ratio (5.537) is slightly higher than the industry average of (3.867).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks